



{"id":93,"date":"2014-09-15T18:18:05","date_gmt":"2014-09-15T18:18:05","guid":{"rendered":"http:\/\/research.unl.edu\/annualreport\/2014\/wp-content\/uploads\/2014\/09\/140717_Guo_005.jpg"},"modified":"2014-09-15T18:18:05","modified_gmt":"2014-09-15T18:18:05","slug":"140717_guo_005","status":"inherit","type":"attachment","link":"https:\/\/research.unl.edu\/annualreport\/2014\/innovative-approach-to-hiv-vaccine-promising\/140717_guo_005\/","title":{"rendered":"140717_Guo_005"},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","template":"","meta":{"_acf_changed":false},"class_list":["post-93","attachment","type-attachment","status-inherit","hentry"],"acf":[],"description":{"rendered":"<p class=\"attachment\"><a href='https:\/\/research.unl.edu\/annualreport\/2014\/wp-content\/uploads\/2014\/09\/140717_Guo_005.jpg'><img loading=\"lazy\" decoding=\"async\" width=\"450\" height=\"299\" src=\"https:\/\/research.unl.edu\/annualreport\/2014\/wp-content\/uploads\/2014\/09\/140717_Guo_005-450x299.jpg\" class=\"attachment-medium size-medium\" alt=\"\" srcset=\"https:\/\/research.unl.edu\/annualreport\/2014\/wp-content\/uploads\/2014\/09\/140717_Guo_005-450x300.jpg 450w, https:\/\/research.unl.edu\/annualreport\/2014\/wp-content\/uploads\/2014\/09\/140717_Guo_005-900x600.jpg 900w, https:\/\/research.unl.edu\/annualreport\/2014\/wp-content\/uploads\/2014\/09\/140717_Guo_005.jpg 2000w\" sizes=\"auto, (max-width: 450px) 100vw, 450px\" \/><\/a><\/p>\n<p>Using a genetically modified form of the HIV virus, chemist Jiantao Guo, right, synthetic biologist Wei Niu, and virologist Qingsheng Li has developed a promising new approach that could someday lead to a more effective HIV vaccine.  July 17, 2015. Photo by Craig Chandler \/ University Communications<\/p>\n"},"caption":{"rendered":"<p>Using a genetically modified form of the HIV virus, chemist Jiantao Guo, right, synthetic biologist Wei Niu, and virologist Qingsheng Li has developed a promising new approach that could someday lead to a more effective HIV vaccine. July 17, 2015. Photo by Craig Chandler \/ University Communications<\/p>\n"},"alt_text":"","media_type":"image","mime_type":"image\/jpeg","media_details":{"width":2000,"height":1333,"file":"2014\/09\/140717_Guo_005.jpg","sizes":{"thumbnail":{"file":"140717_Guo_005-2000x300.jpg","width":2000,"height":300,"mime_type":"image\/jpeg","source_url":"https:\/\/research.unl.edu\/annualreport\/2014\/wp-content\/uploads\/2014\/09\/140717_Guo_005-2000x300.jpg"},"medium":{"file":"140717_Guo_005-450x299.jpg","width":450,"height":299,"mime_type":"image\/jpeg","source_url":"https:\/\/research.unl.edu\/annualreport\/2014\/wp-content\/uploads\/2014\/09\/140717_Guo_005-450x299.jpg"},"large":{"file":"140717_Guo_005-900x599.jpg","width":900,"height":599,"mime_type":"image\/jpeg","source_url":"https:\/\/research.unl.edu\/annualreport\/2014\/wp-content\/uploads\/2014\/09\/140717_Guo_005-900x599.jpg"},"post-thumbnail":{"file":"140717_Guo_005-672x372.jpg","width":672,"height":372,"mime_type":"image\/jpeg","source_url":"https:\/\/research.unl.edu\/annualreport\/2014\/wp-content\/uploads\/2014\/09\/140717_Guo_005-672x372.jpg"},"large-feature":{"file":"140717_Guo_005-1600x945.jpg","width":1600,"height":945,"mime_type":"image\/jpeg","source_url":"https:\/\/research.unl.edu\/annualreport\/2014\/wp-content\/uploads\/2014\/09\/140717_Guo_005-1600x945.jpg"},"post-feature":{"file":"140717_Guo_005-900x600.jpg","width":900,"height":600,"mime_type":"image\/jpeg","source_url":"https:\/\/research.unl.edu\/annualreport\/2014\/wp-content\/uploads\/2014\/09\/140717_Guo_005-900x600.jpg"},"post-half":{"file":"140717_Guo_005-450x300.jpg","width":450,"height":300,"mime_type":"image\/jpeg","source_url":"https:\/\/research.unl.edu\/annualreport\/2014\/wp-content\/uploads\/2014\/09\/140717_Guo_005-450x300.jpg"},"thumbnail-tall":{"file":"140717_Guo_005-450x600.jpg","width":450,"height":600,"mime_type":"image\/jpeg","source_url":"https:\/\/research.unl.edu\/annualreport\/2014\/wp-content\/uploads\/2014\/09\/140717_Guo_005-450x600.jpg"},"annualReport-full-width":{"file":"140717_Guo_005-1038x576.jpg","width":1038,"height":576,"mime_type":"image\/jpeg","source_url":"https:\/\/research.unl.edu\/annualreport\/2014\/wp-content\/uploads\/2014\/09\/140717_Guo_005-1038x576.jpg"},"full":{"file":"140717_Guo_005.jpg","width":2000,"height":1333,"mime_type":"image\/jpeg","source_url":"https:\/\/research.unl.edu\/annualreport\/2014\/wp-content\/uploads\/2014\/09\/140717_Guo_005.jpg"}},"image_meta":{"aperture":0,"credit":"Office of University Communicati","camera":"","caption":"Using a genetically modified form of the HIV virus, chemist Jiantao Guo, right, synthetic biologist Wei Niu, and virologist Qingsheng Li has developed a promising new approach that could someday lead to a more effective HIV vaccine.  July 17, 2015. Photo by Craig Chandler \/ University Communications","created_timestamp":1405608570,"copyright":"\u00a9 2014, The Board of Regents of the University of Nebraska. All rights reserved.","focal_length":0,"iso":0,"shutter_speed":0,"title":"","orientation":0}},"post":92,"source_url":"https:\/\/research.unl.edu\/annualreport\/2014\/wp-content\/uploads\/2014\/09\/140717_Guo_005.jpg","_links":{"self":[{"href":"https:\/\/research.unl.edu\/annualreport\/2014\/wp-json\/wp\/v2\/media\/93","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/research.unl.edu\/annualreport\/2014\/wp-json\/wp\/v2\/media"}],"about":[{"href":"https:\/\/research.unl.edu\/annualreport\/2014\/wp-json\/wp\/v2\/types\/attachment"}],"author":[{"embeddable":true,"href":"https:\/\/research.unl.edu\/annualreport\/2014\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/research.unl.edu\/annualreport\/2014\/wp-json\/wp\/v2\/comments?post=93"}],"wp:attached-to":[{"embeddable":true,"post_type":"post","id":92,"href":"https:\/\/research.unl.edu\/annualreport\/2014\/wp-json\/wp\/v2\/posts\/92"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}